1. Neoadjuvant Pyrotinib plus Trastuzumab and Chemotherapy for Stage I–III HER2‐Positive Breast Cancer: A Phase II Clinical Trial. (20th October 2020) Authors: Xuhong, Juncheng; Qi, Xiaowei; Tang, Peng; Fan, Linjun; Chen, Li; Zhang, Fan; Tan, Xuanni; Yan, Wenting; Zhong, Ling; He, Cheng; Liang, Yan; Ren, Lin; Wang, Minghao; Zhang, Yi; Jiang, Jun Journal: Oncologist Issue: Volume 25:Number 12(2020) Page Start: e1909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lobaplatin-based neoadjuvant chemotherapy for triple-negative breast cancer: a 5-year follow-up of a randomized, open-label, phase II trial. (June 2022) Authors: Yan, Wenting; Wu, Xiujuan; Wang, Shushu; He, Cheng; Zhong, Ling; Tang, Peng; Ren, Lin; Zhang, Ting; Qi, Xiaowei; Zhang, Yi Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Splicing factor hnRNPA2B1 contributes to tumorigenic potential of breast cancer cells through STAT3 and ERK1/2 signaling pathway. Issue 3 (March 2017) Authors: Hu, Ying; Sun, Zihan; Deng, Jinmu; Hu, Baoquan; Yan, Wenting; Wei, Hongyi; Jiang, Jun Journal: Tumor biology Issue: Volume 39:Issue 3(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hebei loess section in the Anyemaqen Mountains, northeast Tibetan Plateau: a high‐resolution luminescence chronology. (23rd May 2018) Authors: E, Chongyi; Sohbati, Reza; Murray, Andrew S.; Buylaert, Jan‐Pieter; Liu, Xiangjun; Yang, Long; Yuan, Jie; Yan, Wenting Journal: Boreas Issue: Volume 47:Number 4(2018) Page Start: 1170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗